儿童糖尿病酮症酸中毒补液期间和肽素的动力学及其与渗透压的关系
这项前瞻性、观察性、多中心研究纳入28例(20例新诊断)1至16岁1型糖尿病酮症酸中毒患儿,在补液开始后72小时内14个时间点连续测定血清和肽素与渗透压。和肽素从95 pmol/L降至9.7 pmol/L,半衰期7.1小时;渗透压从321 mOsm/kg降至294 mOsm/kg,半衰期4.3小时。新诊断与已知1型糖尿病患儿的和肽素动力学存在差异(P=0.001)。
要点
- 和肽素从95 pmol/L降至9.7 pmol/L,半衰期7.1小时(范围5.1-11.5小时)。
- 血清渗透压从321 mOsm/kg降至294 mOsm/kg,半衰期4.3小时(范围3.0-5.6小时)。
- 渗透压每升高15 mOsm/kg(范围10-21 mOsm/kg),和肽素水平翻倍。
核心结论
- 本研究首次描述了糖尿病酮症酸中毒患儿在高渗状态下的和肽素动力学与动态变化。
- 研究揭示新诊断与已知1型糖尿病患儿的和肽素动力学存在显著差异,可能由长期渗透性利尿和糖尿病酮症酸中毒导致的渗透压感受器及肾脏精氨酸加压素受体水平变化解释。
研究设计与样本
- 前瞻性、观察性、多中心研究。
- 纳入28例因糖尿病酮症酸中毒住院的1型糖尿病患儿(其中20例为新诊断),年龄1至16岁。
- 从补液开始起72小时内共14个时间点连续测定血清和肽素与渗透压。
主要发现
- 和肽素从95 pmol/L(95% CI,55-136 pmol/L)(变异系数158%)降至9.7 pmol/L(95% CI,8.1-11.4 pmol/L)(变异系数31%),50%恢复时间(t1/2)为7.1小时(范围5.1-11.5小时)(114%)。
- 血清渗透压从321 mOsm/kg(范围315-327 mOsm/kg)(4%)降至294 mOsm/kg(范围292-296 mOsm/kg)(1%),t1/2为4.3小时(范围3.0-5.6小时)(64%)。
- 渗透压每升高15 mOsm/kg(范围10-21 mOsm/kg)(59%),和肽素水平翻倍,从9.8 pmol/L(范围7.3-12.3 pmol/L)(48%)至280 mOsm/kg。
- 新诊断与已知1型糖尿病患儿的和肽素动力学存在差异(P=0.001),轻度与中重度糖尿病酮症酸中毒之间的差异较小(P=0.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Copeptin is a surrogate marker for arginine vasopressin (AVP) release in response to hyperosmolal stimuli such as diabetic ketoacidosis (DKA). OBJECTIVE: The objective of this work is to characterize kinetics of copeptin and osmolality, and their dynamic relationship during rehydration and insulin therapy in children with type 1 diabetes (T1D) and DKA. DESIGN AND SETTING: A prospective, observational, multicenter study was conducted. PATIENTS AND INTERVENTION: Children with T1D admitted for DKA underwent serial serum copeptin and osmolality measurements from start of rehydration at 14 time points during 72 hours. MAIN OUTCOME MEASURES: Measurements included temporal course of copeptin and osmolality (kinetics), relationship between both (dynamics), and association between-subject variability (BSV) (coefficient of variation, CV%). RESULTS: Twenty-eight children (20 newly diagnosed T1D) aged 1 to 16 years were included. Copeptin decreased from 95 pmol/L (95% CI, 55-136 pmol/L) (CV%, 158%) to 9.7 pmol/L (95% CI, 8.1-11.4 pmol/L) (CV%, 31%) with a 50% recovery time (t1/2) of 7.1 hours (range, 5.1-11.5 hours) (114%). Serum osmolality decreased from 321 mOsm/kg (range, 315-327 mOsm/kg) (4%) to 294 mOsm/kg (range, 292-296 mOsm/kg) (1%) with a t1/2 of 4.3 hours (range, 3.0-5.6 hours) (64%). Copeptin levels doubled with each osmolality increase by 15 mOsm/kg (range, 10-21 mOsm/kg) (59%), from 9.8 pmol/L (range, 7.3-12.3 pmol/L) (48%) to 280 mOsm/kg. Copeptin kinetics differed between newly diagnosed and known T1D patients (P = .001), and less between mild vs moderate-severe DKA (P = .04). CONCLUSIONS: First, this study characterized for the first time copeptin kinetics and dynamics in the high hyperosmolar range in children with DKA. Second, it revealed significant differences in copeptin kinetics between newly diagnosed and known T1D patients that may be explained by changes at the osmoreceptor and renal AVP receptor level due to longstanding osmotic diuresis and DKA.
引用
- Burckhardt MA, Gotta V, Beglinger S, et al. Copeptin Kinetics and Its Relationship to Osmolality During Rehydration for Diabetic Ketoacidosis in Children. J Clin Endocrinol Metab. 2020. PMID: 32835363. doi:10.1210/clinem/dgaa568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。